Aspira Women's Health Inc. also files under AWHL, VRML, VRML.OB, CIPH; those filings are included. Filings under AWH by Allied World Assurance Co Holdings, AG (CIK 0001163348) from Jul 11, 2006 to Jul 6, 2017 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Strahley John | Chief Financial Officer | Grant(A) | 70K | — | $0 |
| Jun 5, 2026 | Schuler Jack W | 10% Owner | Buy(P) | 222K | $0.45 | $100K |
| Jun 5, 2026 | Schuler Jack W | 10% Owner | Buy(P) | 300K | — | $0 |
| Dec 2, 2025 | Parnell Winfred | Director | Grant(A) | 185K | — | $0 |
| Dec 2, 2025 | Fraser John D | Director | Grant(A) | 315K | — | $0 |
| Dec 2, 2025 | Beausang Ellen | Director | Grant(A) | 198K | — | $0 |
| Dec 2, 2025 | cohen Jeffrey k | Director | Grant(A) | 214K | — | $0 |
| Dec 2, 2025 | Wood Jane Pine | Director | Grant(A) | 136K | — | $0 |
| Dec 2, 2025 | Hundorfean Cynthia D | Director | Grant(A) | 238K | — | $0 |
| Sep 17, 2025 | cohen Jeffrey k | Director | Buy(P) | 42K | — | $0 |
| Sep 17, 2025 | Fraser John D | Director | Buy(P) | 12K | — | $0 |
| Sep 17, 2025 | Fraser John D | Director | Buy(P) | 16K | $0.45 | $7K |
| Sep 17, 2025 | cohen Jeffrey k | Director | Other(J) | 11K | $0.45 | $5K |
| Sep 17, 2025 | Schuler Jack W | 10% Owner | Buy(P) | 833K | — | $0 |
| Sep 17, 2025 | Schuler Jack W | 10% Owner | Buy(P) | 1.1M | $0.45 | $500K |
| Sep 17, 2025 | cohen Jeffrey k | Director | Buy(P) | 56K | $0.45 | $25K |
| Sep 2, 2025 | Hungerford Brian | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Jun 4, 2025 | Beausang Ellen | Director | Option exercise(M) | 5K | — | $0 |
| Jun 4, 2025 | Herchuk Jannie Prestridge | Director | Option exercise(M) | 8K | — | $0 |
| Jun 4, 2025 | Beausang Ellen | Director | Option exercise(M) | 5K | — | $0 |
| Jun 4, 2025 | Vos Ellen O'Connor | Director | Option exercise(M) | 5K | — | $0 |
| Jun 4, 2025 | Vos Ellen O'Connor | Director | Option exercise(M) | 5K | — | $0 |
| Jun 4, 2025 | Ragard John Phillip | Director | Option exercise(M) | 5K | — | $0 |
| Jun 4, 2025 | Ragard John Phillip | Director | Option exercise(M) | 5K | — | $0 |
| Jun 4, 2025 | Cavanaugh Stefanie L. | Director | Option exercise(M) | 6K | — | $0 |
| Jun 4, 2025 | Herchuk Jannie Prestridge | Director | Option exercise(M) | 8K | — | $0 |
| Jun 4, 2025 | Cavanaugh Stefanie L. | Director | Option exercise(M) | 6K | — | $0 |
| Jun 4, 2025 | Parnell Winfred | Director | Option exercise(M) | 5K | — | $0 |
| Jun 4, 2025 | Parnell Winfred | Director | Option exercise(M) | 5K | — | $0 |
| May 22, 2025 | Buhle Michael William | Chief Executive Officer | Grant(A) | 100K | — | $0 |
| May 13, 2025 | cohen Jeffrey k | Director | Grant(A) | 12K | $0.07 | $816 |
| May 9, 2025 | cohen Jeffrey k | Director | Grant(A) | 44K | $0.07 | $3K |
| Mar 31, 2025 | Cavanaugh Stefanie L. | Director | Option exercise(M) | 6K | — | $0 |
| Mar 31, 2025 | Cavanaugh Stefanie L. | Director | Option exercise(M) | 6K | — | $0 |
| Mar 31, 2025 | Vos Ellen O'Connor | Director | Option exercise(M) | 5K | — | $0 |
| Mar 31, 2025 | Ragard John Phillip | Director | Option exercise(M) | 5K | — | $0 |
| Mar 31, 2025 | Vos Ellen O'Connor | Director | Option exercise(M) | 5K | — | $0 |
| Mar 31, 2025 | Parnell Winfred | Director | Option exercise(M) | 5K | — | $0 |
| Mar 31, 2025 | Fralick Celeste Rachelle | Director | Option exercise(M) | 5K | — | $0 |
| Mar 31, 2025 | Beausang Ellen | Director | Option exercise(M) | 2K | — | $0 |
| Mar 31, 2025 | Parnell Winfred | Director | Option exercise(M) | 5K | — | $0 |
| Mar 31, 2025 | Beausang Ellen | Director | Option exercise(M) | 2K | — | $0 |
| Mar 31, 2025 | Ragard John Phillip | Director | Option exercise(M) | 5K | — | $0 |
| Mar 31, 2025 | Herchuk Jannie Prestridge | Director | Option exercise(M) | 8K | — | $0 |
| Mar 31, 2025 | Herchuk Jannie Prestridge | Director | Option exercise(M) | 8K | — | $0 |
| Mar 31, 2025 | Fralick Celeste Rachelle | Director | Option exercise(M) | 5K | — | $0 |
| Mar 11, 2025 | Beausang Ellen | Director | Grant(A) | 6K | — | $0 |
| Mar 6, 2025 | Schuler Jack W | 10% Owner | Buy(P) | 0 | $200,000.00as filed | — |
| Jan 8, 2025 | Milligan Sandra | Interim CEO | Tax withholding(F) | 6K | $0.70 | $4K |
| Dec 31, 2024 | Ragard John Phillip | Director | Option exercise(M) | 5K | — | $0 |
| Dec 31, 2024 | Milligan Sandra | Interim CEO | Option exercise(M) | 20K | — | $0 |
| Dec 31, 2024 | Vos Ellen O'Connor | Director | Option exercise(M) | 5K | — | $0 |
| Dec 31, 2024 | Ragard John Phillip | Director | Option exercise(M) | 5K | — | $0 |
| Dec 31, 2024 | Parnell Winfred | Director | Option exercise(M) | 5K | — | $0 |
| Dec 31, 2024 | Parnell Winfred | Director | Option exercise(M) | 5K | — | $0 |
| Dec 31, 2024 | Herchuk Jannie Prestridge | Director | Option exercise(M) | 8K | — | $0 |
| Dec 31, 2024 | Herchuk Jannie Prestridge | Director | Option exercise(M) | 8K | — | $0 |
| Dec 31, 2024 | Fralick Celeste Rachelle | Director | Option exercise(M) | 5K | — | $0 |
| Dec 31, 2024 | Fralick Celeste Rachelle | Director | Option exercise(M) | 5K | — | $0 |
| Dec 31, 2024 | Milligan Sandra | Interim CEO | Option exercise(M) | 20K | — | $0 |
| Dec 31, 2024 | Cavanaugh Stefanie L. | Director | Option exercise(M) | 6K | — | $0 |
| Dec 31, 2024 | Cavanaugh Stefanie L. | Director | Option exercise(M) | 6K | — | $0 |
| Dec 31, 2024 | Vos Ellen O'Connor | Director | Option exercise(M) | 5K | — | $0 |
| Nov 12, 2024 | Kallassy John A | Interim CFO | Grant(A) | 25K | — | $0 |
| Nov 12, 2024 | Milligan Sandra | President | Grant(A) | 25K | — | $0 |
| Oct 28, 2024 | Milligan Sandra | President | Grant(A) | 20K | — | $0 |
| Oct 28, 2024 | Sandford Nicole | Chief Executive Officer, Director | Grant(A) | 25K | — | $0 |
| Sep 30, 2024 | Cavanaugh Stefanie L. | Director | Option exercise(M) | 6K | — | $0 |
| Sep 30, 2024 | Cavanaugh Stefanie L. | Director | Option exercise(M) | 6K | — | $0 |
| Sep 30, 2024 | Vos Ellen O'Connor | Director | Option exercise(M) | 5K | — | $0 |
| Sep 30, 2024 | Vos Ellen O'Connor | Director | Option exercise(M) | 5K | — | $0 |
| Sep 30, 2024 | Ragard John Phillip | Director | Option exercise(M) | 5K | — | $0 |
| Sep 30, 2024 | Fralick Celeste Rachelle | Director | Option exercise(M) | 5K | — | $0 |
| Sep 30, 2024 | Fralick Celeste Rachelle | Director | Option exercise(M) | 5K | — | $0 |
| Sep 30, 2024 | Ragard John Phillip | Director | Option exercise(M) | 5K | — | $0 |
| Sep 30, 2024 | Parnell Winfred | Director | Option exercise(M) | 5K | — | $0 |
| Sep 30, 2024 | Parnell Winfred | Director | Option exercise(M) | 5K | — | $0 |
| Sep 30, 2024 | Herchuk Jannie Prestridge | Director | Option exercise(M) | 8K | — | $0 |
| Sep 30, 2024 | Herchuk Jannie Prestridge | Director | Option exercise(M) | 8K | — | $0 |
| Aug 22, 2024 | Vos Ellen O'Connor | Director | Grant(A) | 21K | — | $0 |
| Aug 22, 2024 | Ragard John Phillip | Director | Grant(A) | 19K | — | $0 |
| Aug 22, 2024 | Herchuk Jannie Prestridge | Director | Grant(A) | 34K | — | $0 |
| Aug 22, 2024 | Fralick Celeste Rachelle | Director | Grant(A) | 20K | — | $0 |
| Aug 22, 2024 | Cavanaugh Stefanie L. | Director | Grant(A) | 24K | — | $0 |
| Aug 22, 2024 | Parnell Winfred | Director | Grant(A) | 21K | — | $0 |
| Aug 15, 2024 | Kallassy John A | Interim CFO | Grant(A) | 25K | — | $0 |
| Aug 12, 2024 | Fralick Celeste Rachelle | Director | Grant(A) | 15K | — | $0 |
| Aug 12, 2024 | Parnell Winfred | Director | Grant(A) | 16K | — | $0 |
| Aug 12, 2024 | Herchuk Jannie Prestridge | Director | Grant(A) | 20K | — | $0 |
| Aug 12, 2024 | Cavanaugh Stefanie L. | Director | Grant(A) | 17K | — | $0 |
| Aug 12, 2024 | Vos Ellen O'Connor | Director | Grant(A) | 17K | — | $0 |
| Jul 9, 2024 | Schuler Jack W | 10% Owner | Buy(P) | 7K | — | — |
| Jul 9, 2024 | Sandford Nicole | CEO, Director | Grant(A) | 13K | — | — |
| Jul 9, 2024 | Sandford Nicole | CEO, Director | Grant(A) | 13K | — | — |
| Jul 9, 2024 | Cavanaugh Stefanie L. | Director | Grant(A) | 3K | — | — |
| Jul 9, 2024 | Cavanaugh Stefanie L. | Director | Grant(A) | 3K | — | — |
| Jul 9, 2024 | Parnell Winfred | Director | Grant(A) | 3K | — | — |
| Jul 9, 2024 | Parnell Winfred | Director | Grant(A) | 3K | — | — |
| Jul 9, 2024 | Herchuk Jannie Prestridge | Director | Grant(A) | 5K | — | — |
| Jul 9, 2024 | Herchuk Jannie Prestridge | Director | Grant(A) | 5K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Aspira Women's Health Inc., SEC CIK 0000926617. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under AWH and shows every filing by that issuer (also filed as AWHL, VRML, VRML.OB, CIPH). Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-08. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for AWH